Improvement of urinary symptoms after bladder biopsy: A case of pathologically proven allergy-related cystitis during administration of nivolumab.

adverse drug event cystitis lung neoplasms nivolumab urinary bladder

Journal

IJU case reports
ISSN: 2577-171X
Titre abrégé: IJU Case Rep
Pays: Australia
ID NLM: 101764958

Informations de publication

Date de publication:
Jul 2021
Historique:
received: 21 01 2021
accepted: 10 03 2021
entrez: 26 7 2021
pubmed: 27 7 2021
medline: 27 7 2021
Statut: epublish

Résumé

We present a case of cystitis, which was considered to be an immune-related adverse event associated with nivolumab administration. A 47-year-old man suffered from sudden onset urinary symptoms after 18 cycles of nivolumab treatment for stage IV pulmonary adenocarcinoma. Urine culture and urine cytology were both negative. The symptoms were inferred to be related to nivolumab administration, and a bladder biopsy under spinal anesthesia was performed. The histopathological examination showed the evidence of allergic-related cystitis. We planned to administer corticosteroids, but the urinary symptoms disappeared after the bladder biopsy. Nivolumab treatment was continued without recurrent bladder symptoms. We reported a case of cystitis after treatment with nivolumab, which served as a reminder to consider the possibility of immune-related adverse events as a potential cause for any symptoms that develop during treatment with immuno-oncology drugs.

Identifiants

pubmed: 34308272
doi: 10.1002/iju5.12286
pii: IJU512286
pmc: PMC8294138
doi:

Types de publication

Case Reports

Langues

eng

Pagination

213-215

Informations de copyright

© 2021 The Authors. IJU Case Reports published by John Wiley & Sons Australia, Ltd on behalf of the Japanese Urological Association.

Déclaration de conflit d'intérêts

All human subjects provided written informed consent with guarantees of confidentiality.The authors declare no conflict of interest.

Références

Am J Pathol. 2018 Nov;188(11):2446-2456
pubmed: 30142332
Sci Rep. 2012;2:317
pubmed: 22432050
J Dtsch Dermatol Ges. 2016 Jul;14(7):662-81
pubmed: 27373241
Urol Case Rep. 2018 Jan 28;17:97-99
pubmed: 29541592
BJU Int. 2009 Feb;103(4):541-6
pubmed: 18990151
N Engl J Med. 2015 Jul 2;373(1):23-34
pubmed: 26027431
Int Cancer Conf J. 2017 May 9;6(4):164-166
pubmed: 31149494

Auteurs

Shugo Yajima (S)

National Cancer Center Hospital East Kashiwa, Chiba Japan.

Yasukazu Nakanishi (Y)

National Cancer Center Hospital East Kashiwa, Chiba Japan.

Shunya Matsumoto (S)

National Cancer Center Hospital East Kashiwa, Chiba Japan.

Kenji Tanabe (K)

National Cancer Center Hospital East Kashiwa, Chiba Japan.

Masato Sugano (M)

National Cancer Center Hospital East Kashiwa, Chiba Japan.

Hitoshi Masuda (H)

National Cancer Center Hospital East Kashiwa, Chiba Japan.

Classifications MeSH